Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Mirion Technologies Inc (MIR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/28/2025: MIR (5-star) is a SELL. SELL since 5 days. Simulated Profits (-4.53%). Updated daily EoD!
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $31
1 Year Target Price $31
| 3 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 61.46% | Avg. Invested days 35 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/28/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.36B USD | Price to earnings Ratio 236.55 | 1Y Target Price 31 |
Price to earnings Ratio 236.55 | 1Y Target Price 31 | ||
Volume (30-day avg) 5 | Beta 0.93 | 52 Weeks Range 12.00 - 30.28 | Updated Date 11/30/2025 |
52 Weeks Range 12.00 - 30.28 | Updated Date 11/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.94% | Operating Margin (TTM) 3.77% |
Management Effectiveness
Return on Assets (TTM) 1.18% | Return on Equity (TTM) 1.61% |
Valuation
Trailing PE 236.55 | Forward PE - | Enterprise Value 6809681267 | Price to Sales(TTM) 7.05 |
Enterprise Value 6809681267 | Price to Sales(TTM) 7.05 | ||
Enterprise Value to Revenue 7.55 | Enterprise Value to EBITDA 32.63 | Shares Outstanding 244370206 | Shares Floating 211339200 |
Shares Outstanding 244370206 | Shares Floating 211339200 | ||
Percent Insiders 3.72 | Percent Institutions 105.13 |
Upturn AI SWOT
Mirion Technologies Inc
Company Overview
History and Background
Mirion Technologies, Inc. was formed in 2006, though its constituent businesses have a much longer history in radiation detection and measurement, dating back to the early 20th century. The company consolidates several established brands in the industry, evolving into a provider of radiation detection, measurement, analysis, and monitoring solutions.
Core Business Areas
- Medical: Provides radiation measurement and quality assurance solutions for diagnostic imaging, radiation therapy, and nuclear medicine applications. This ensures safe and effective radiation use in healthcare.
- Defense: Supplies radiation detection and monitoring equipment for military personnel, homeland security, and emergency responders to protect against radiation threats.
- Industrial: Offers radiation monitoring and measurement tools for nuclear power plants, industrial facilities, and environmental monitoring applications. This ensures safety and compliance in these settings.
Leadership and Structure
Mirion Technologies is led by its CEO, Thomas Logan, along with a senior management team overseeing various business units and functions. The company operates with a matrix organizational structure.
Top Products and Market Share
Key Offerings
- Instadose Dosimeters: Personal radiation monitoring devices used in healthcare, nuclear power, and defense. Mirion is a leader in this market. Competitors include Landauer and Thermo Fisher Scientific. Market share data is proprietary.
- RDS-200 Survey Meter: Handheld radiation survey meter used for general radiation detection in various industries. Competitors include Thermo Fisher Scientific and Ludlum Measurements. Market share data is proprietary.
- Accu-Gold Densitometers: Used in diagnostic imaging for quality assurance of x-ray equipment. Competitors include Unfors RaySafe and RTI Group. Market share data is proprietary.
Market Dynamics
Industry Overview
The radiation detection and measurement market is driven by increasing safety regulations, growing nuclear power generation, and heightened security concerns. Technological advancements are leading to more sensitive and accurate detection systems.
Positioning
Mirion Technologies is a leading provider of radiation detection and measurement solutions, known for its established brands and comprehensive product portfolio. Its competitive advantage lies in its breadth of offerings and global presence.
Total Addressable Market (TAM)
The global radiation detection and monitoring market is projected to reach billions of dollars. Mirion is well-positioned to capture a significant portion of this market with its diverse product line.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Comprehensive product portfolio
- Global presence and distribution network
- Advanced technology and innovation
Weaknesses
- Reliance on regulated industries
- Competition from larger diversified companies
- Potential impact of economic downturns
- Customer concentration risk.
Opportunities
- Expanding nuclear power generation
- Increasing demand for homeland security solutions
- Growing applications in medical imaging and therapy
- Emerging markets growth.
Threats
- Changes in government regulations
- Technological obsolescence
- Cybersecurity threats
- Economic slowdown.
Competitors and Market Share
Key Competitors
- TMO
- FLIR
Competitive Landscape
Mirion faces competition from larger, more diversified companies like Thermo Fisher Scientific and Teledyne FLIR. Mirion focuses on niche markets, using specialized technology to compete.
Major Acquisitions
Canberra
- Year: 2016
- Acquisition Price (USD millions): 155
- Strategic Rationale: Expanded Mirion's product portfolio in nuclear measurement and analysis.
Growth Trajectory and Initiatives
Historical Growth: Data unavailable.
Future Projections: Analyst estimates projects continued growth driven by expansion into new markets and innovation.
Recent Initiatives: Mirion is focusing on expanding its service offerings and developing cloud-based solutions.
Summary
Mirion Technologies is a prominent player in radiation detection and measurement, benefiting from a strong brand and comprehensive offerings. The company's success is tied to regulatory compliance and increasing demand for safety solutions. Mirion should focus on mitigating competition and adapting to technological changes to maintain its growth trajectory. Key areas include expanding service offerings and leveraging emerging markets.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- Market Reports
- Industry Analysis
- Financial News Articles
Disclaimers:
This analysis is based on available information and is not financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mirion Technologies Inc
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2020-08-20 | Founder, Medical Group President, CEO & Chairman Mr. Thomas D. Logan | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 2860 | Website https://www.mirion.com |
Full time employees 2860 | Website https://www.mirion.com | ||
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.